UBS Lowers Oracle Price Target to $250
UBS analyst Karl Keirstead lowered the price target on Oracle (NYSE: ORCL) to $250.00 (from $280.00) while maintaining a Buy rating.
“Right ahead of a planned debt issuance, Oracle press-released some incremental disclosures about its funding needs in 2026, required to finance the build-out of AI infrastructure.
Oracle disclosed that it will raise $45-50 billion in cash in 2026 via a roughly equal balance of debt and equity and that it remains committed to its investment grade rating.
The planned debt raise of “only” $20-25 billion coupled with an equity raise of up to $20 billion will likely come as a relief to credit investors while the equity raise (which Oracle has long described as a last resort) may not be warmly received by all equity holders.
We are Buy-rated and wonder if this long-awaited clarity may serve as a clearing event for the stock.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
